Skip to content

Pregnancies Before the Diagnosis of Systemic Lupus Erythematosus

Pregnancy Outcomes Prior to a Systemic Lupus Erythematosus Diagnosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07148115
Acronym
PREDILUP
Enrollment
50
Registered
2025-08-29
Start date
2025-01-01
Completion date
2026-04-30
Last updated
2025-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Complications, SLE

Keywords

Pregnancy, SLE, Obstetrical events

Brief summary

This is an observational, monocentric, retrospective cohort study. Its primary objective is to examine maternal and foetal outcomes in pregnancies that occurred before the diagnosis of systemic lupus erythematosus (SLE) in a group of female participants who were subsequently diagnosed with the condition.

Detailed description

The investigators aim to study obstetrical and systemic signs in participants' pregnancies prior to an SLE diagnosis. Information will be collected from medical records and by asking participants questions during medical visits. The diagnosis of SLE is made using the ACR 1997 criteria. It is also based on renal histological findings. The study must answer three questions: 1. Are systemic signs of SLE present before or during pregnancy? 2. What were the fetal and maternal outcomes after or during each pregnancy? What is/was the severity of SLE after diagnosis?

Interventions

OTHERCollect data on all pregnancies before and after diagnosis of SLE.

For participants who are still alive, data are collected from interviews with patients using a prepared questionnaire that asks about all pregnancies and obstetrical events prior to the diagnosis of SLE. For deceased patients, data are taken from the medical records of obstetrical events. Data will be collected on anthropometric, biological, immunological, and histological features before and after the diagnosis of SLE, if available. The activity and severity of the disease after diagnosis will be assessed using the recommended tools.

Sponsors

University of Algiers
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Women of childbearing age with a history of at least one pregnancy * Pregnancy occurred before the diagnosis of LES. * LES was diagnosed after at least one pregnancy. * The subject is classified as having LES according to the 1997 ACR or EULAR 2019 criteria.

Exclusion criteria

LES was previously diagnosed prior to any conception.

Design outcomes

Primary

MeasureTime frameDescription
1. Primary outcome: Prevalence of obstetrical events before the diagnosis of SLE. Secondary outcome: 1. Assess the severity of the disease at the time of LES diagnosis. 2. Compare the outcomes of pregnancies before and after the LESThe patient will be assessed from the beginning of each pregnancy and in the three month after childbirth* Evaluate the number of pregnancies for each woman before and after the diagnosis of lupus. * Assess obstetric events for each pregnancy (spontaneous abortion, prematurity, fetal death, pre-eclampsia, HELLP syndrome, or other pregnancy-related events). * Assess the presence of systemic signs during pregnancy or the postpartum period. * Collect data on the baby's status, including weight, height, and any morbid conditions (dermatological, cardiac, respiratory, etc.). * Note the timeframe between the last pregnancy or delivery and the SLE diagnosis.

Countries

Algeria

Contacts

Primary ContactWafia- Nadia Nibouche - Hattab, Professor in medicine
wani16000@yahoo.fr+213-771-810-932

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026